JP2005510539A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005510539A5 JP2005510539A5 JP2003546859A JP2003546859A JP2005510539A5 JP 2005510539 A5 JP2005510539 A5 JP 2005510539A5 JP 2003546859 A JP2003546859 A JP 2003546859A JP 2003546859 A JP2003546859 A JP 2003546859A JP 2005510539 A5 JP2005510539 A5 JP 2005510539A5
- Authority
- JP
- Japan
- Prior art keywords
- coating layer
- poly
- methacrylic acid
- methyl methacrylate
- inner coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011247 coating layer Substances 0.000 claims 23
- 239000000203 mixture Substances 0.000 claims 18
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 13
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 12
- 239000013543 active substance Substances 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000007892 solid unit dosage form Substances 0.000 claims 4
- 239000007888 film coating Substances 0.000 claims 3
- 238000009501 film coating Methods 0.000 claims 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 claims 3
- 229960004963 mesalazine Drugs 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 229920002301 cellulose acetate Polymers 0.000 claims 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 2
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims 2
- 229920000193 polymethacrylate Polymers 0.000 claims 2
- 239000007909 solid dosage form Substances 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- 244000215068 Acacia senegal Species 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920000084 Gum arabic Polymers 0.000 claims 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- 235000003421 Plantago ovata Nutrition 0.000 claims 1
- 244000134552 Plantago ovata Species 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- -1 Propio Chemical class 0.000 claims 1
- 239000009223 Psyllium Substances 0.000 claims 1
- 229920001800 Shellac Polymers 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 229920002494 Zein Polymers 0.000 claims 1
- 235000010489 acacia gum Nutrition 0.000 claims 1
- 239000000205 acacia gum Substances 0.000 claims 1
- UTKBLLDLHPDWDU-ODZAUARKSA-N acetic acid;(z)-but-2-enedioic acid Chemical compound CC(O)=O.OC(=O)\C=C/C(O)=O UTKBLLDLHPDWDU-ODZAUARKSA-N 0.000 claims 1
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000001088 anti-asthma Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 239000000924 antiasthmatic agent Substances 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 239000003908 antipruritic agent Substances 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 239000002327 cardiovascular agent Substances 0.000 claims 1
- 229940125692 cardiovascular agent Drugs 0.000 claims 1
- 239000004203 carnauba wax Substances 0.000 claims 1
- 235000013869 carnauba wax Nutrition 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 1
- 229920003086 cellulose ether Polymers 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000007891 compressed tablet Substances 0.000 claims 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 239000003862 glucocorticoid Substances 0.000 claims 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 claims 1
- 239000010903 husk Substances 0.000 claims 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 229940125721 immunosuppressive agent Drugs 0.000 claims 1
- 239000008141 laxative Substances 0.000 claims 1
- 230000002475 laxative effect Effects 0.000 claims 1
- 229920003113 low viscosity grade hydroxypropyl cellulose Polymers 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 229940001470 psychoactive drug Drugs 0.000 claims 1
- 239000004089 psychotropic agent Substances 0.000 claims 1
- 229940070687 psyllium Drugs 0.000 claims 1
- 239000004208 shellac Substances 0.000 claims 1
- 229940113147 shellac Drugs 0.000 claims 1
- 235000013874 shellac Nutrition 0.000 claims 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 125000005591 trimellitate group Chemical group 0.000 claims 1
- 239000001993 wax Substances 0.000 claims 1
- 239000005019 zein Substances 0.000 claims 1
- 229940093612 zein Drugs 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2001/043893 WO2003045356A1 (en) | 2000-11-20 | 2001-11-23 | Pharmaceutical dosage form with multiple coatings |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012040514A Division JP2012107058A (ja) | 2012-02-27 | 2012-02-27 | 複数のコーティングを有する医薬剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005510539A JP2005510539A (ja) | 2005-04-21 |
| JP2005510539A5 true JP2005510539A5 (enExample) | 2005-12-22 |
| JP4999037B2 JP4999037B2 (ja) | 2012-08-15 |
Family
ID=32823137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003546859A Expired - Lifetime JP4999037B2 (ja) | 2001-11-23 | 2001-11-23 | 複数のコーティングを有する医薬剤形 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1453487B2 (enExample) |
| JP (1) | JP4999037B2 (enExample) |
| CN (1) | CN1314390C (enExample) |
| AT (1) | ATE389389T1 (enExample) |
| AU (1) | AU2002226955B2 (enExample) |
| BR (1) | BRPI0117180B8 (enExample) |
| DE (1) | DE60133319T3 (enExample) |
| DK (1) | DK1453487T3 (enExample) |
| ES (1) | ES2301575T5 (enExample) |
| HU (1) | HU231030B1 (enExample) |
| IL (1) | IL161628A (enExample) |
| MX (1) | MXPA04004747A (enExample) |
| NZ (1) | NZ532564A (enExample) |
| PT (1) | PT1453487E (enExample) |
| WO (1) | WO2003045356A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
| CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| US8168170B2 (en) | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
| MXPA06000852A (es) * | 2003-07-24 | 2006-03-30 | Smithkline Beecham Corp | Peliculas que se disuelven oralmente. |
| GB2407501A (en) * | 2003-11-03 | 2005-05-04 | Ist Superiore Sanita | Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
| US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
| US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| CN101010069B (zh) * | 2004-09-01 | 2011-11-23 | 宝洁公司 | 包含5-氨基-2-羟基苯甲酸和还原糖的组合物 |
| EP1885383B1 (en) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Feline probiotic bifidobacteria |
| WO2006130187A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
| MX2009008166A (es) | 2007-02-01 | 2009-08-12 | Iams Company | Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate. |
| HUE046488T2 (hu) * | 2007-05-07 | 2020-03-30 | Evonik Operations Gmbh | Gyorsított drogfelszabadulást biztosító, bélben oldódó bevonatot tartalmazó szilárd adagolási forma |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| GB201202433D0 (en) | 2012-02-13 | 2012-03-28 | Diurnal Ltd | Controlled drug release |
| JP2012107058A (ja) * | 2012-02-27 | 2012-06-07 | Warner Chilcott Co Llc | 複数のコーティングを有する医薬剤形 |
| US20140141075A1 (en) * | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
| GB2510754B (en) * | 2013-02-12 | 2016-07-13 | Diurnal Ltd | Controlled drug release |
| CN105025888B (zh) * | 2013-02-22 | 2018-10-12 | 志瑞亚新药工业株式会社 | 肠溶片 |
| JP6165022B2 (ja) * | 2013-10-30 | 2017-07-19 | 株式会社ファンケル | 放出制御型ソフトカプセル剤 |
| WO2016001843A1 (en) * | 2014-06-30 | 2016-01-07 | Sun Pharmaceutical Industries Limited | Extended-release gastroretentive tablets of voglibose |
| EP3162362A1 (de) * | 2015-10-30 | 2017-05-03 | Dr. Falk Pharma Gmbh | Optimierte mesalazinhaltige hochdosistablette |
| CN107661370A (zh) * | 2017-11-20 | 2018-02-06 | 贵州浩诚药业有限公司 | 一种苦参片及其制备方法 |
| WO2019211419A1 (en) * | 2018-05-03 | 2019-11-07 | M.W. Encap Limited | Dosage forms for delivery of medicines to the lower gastrointestinal tract |
| EP3613414A1 (de) | 2018-08-24 | 2020-02-26 | Dr. Falk Pharma Gmbh | Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon |
| US11523992B2 (en) * | 2019-05-15 | 2022-12-13 | Evonik Operations Gmbh | Process for preparing filled hard-shell capsules with (meth)acrylate copolymer based coatings with a capsule-filling machine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| CN1239425A (zh) * | 1996-11-15 | 1999-12-22 | 普罗克特和甘保尔公司 | 供结肠释放的具有多层肠溶聚合物包衣的药剂 |
| AU5310898A (en) * | 1996-12-20 | 1998-07-17 | Dumex-Alpharma A/S | Release-controlled coated tablets |
-
2001
- 2001-11-23 JP JP2003546859A patent/JP4999037B2/ja not_active Expired - Lifetime
- 2001-11-23 EP EP01995903.0A patent/EP1453487B2/en not_active Expired - Lifetime
- 2001-11-23 WO PCT/US2001/043893 patent/WO2003045356A1/en not_active Ceased
- 2001-11-23 NZ NZ532564A patent/NZ532564A/en not_active IP Right Cessation
- 2001-11-23 AT AT01995903T patent/ATE389389T1/de active
- 2001-11-23 DE DE60133319.5T patent/DE60133319T3/de not_active Expired - Lifetime
- 2001-11-23 CN CNB018238009A patent/CN1314390C/zh not_active Expired - Lifetime
- 2001-11-23 BR BR0117180A patent/BRPI0117180B8/pt not_active IP Right Cessation
- 2001-11-23 PT PT01995903T patent/PT1453487E/pt unknown
- 2001-11-23 MX MXPA04004747A patent/MXPA04004747A/es active IP Right Grant
- 2001-11-23 AU AU2002226955A patent/AU2002226955B2/en not_active Expired
- 2001-11-23 DK DK01995903T patent/DK1453487T3/da active
- 2001-11-23 ES ES01995903T patent/ES2301575T5/es not_active Expired - Lifetime
- 2001-11-23 HU HU0402230A patent/HU231030B1/hu unknown
-
2004
- 2004-04-26 IL IL161628A patent/IL161628A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005510539A5 (enExample) | ||
| JP4999037B2 (ja) | 複数のコーティングを有する医薬剤形 | |
| AU654277B2 (en) | Controlled release drug formulation | |
| CN1404389B (zh) | 时控脉冲给药系统 | |
| JP3902229B2 (ja) | 結腸デリバリー用の、多腸溶ポリマー被覆物を有する医薬投与形態 | |
| EP0827398B1 (en) | Pharmaceutical dosage form for colonic delivery | |
| CN102970983B (zh) | 耐受酒精的口服药物制剂 | |
| JPH10203983A5 (enExample) | ||
| JP2001509157A (ja) | 時間特異的放出制御型投与製剤及びその製法 | |
| JP2007532689A (ja) | 医薬有効成分の遅延性かつ調節性放出のための微粒子経口ガレヌス製剤 | |
| JP2792904B2 (ja) | 有効物質を制御して放出する経口投与用の薬学的製剤、及びその製造方法 | |
| JP2017532363A5 (enExample) | ||
| JP2009512699A5 (enExample) | ||
| CN107205937A (zh) | 包含富马酸二甲酯的药物珠粒制剂 | |
| KR20070069105A (ko) | 서방성 제제 | |
| JP5674671B2 (ja) | 塩酸シプロヘプタジン軟膏剤及びその製造方法 | |
| WO2010069141A1 (zh) | 具有润滑层结构的双层渗透泵控释片及其制备方法 | |
| EP1283701A1 (en) | A coating composition for facilitating controlled release | |
| WO2009006299A2 (en) | Multi-particulate systems | |
| WO1998022096A1 (en) | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery | |
| CN104856971B (zh) | 一种脉冲双释放制剂及其制备方法与应用 | |
| JP2003510347A (ja) | 抗炎症医薬品製剤 | |
| WO2006117803A2 (en) | Transmucosal drug delivery systems | |
| CN101259112A (zh) | 盐酸沙格雷酯单层渗透泵控释制剂及其制备方法 | |
| JP2012107058A (ja) | 複数のコーティングを有する医薬剤形 |